Pulmonx Corporation (LUNG)
NASDAQ: LUNG · Real-Time Price · USD
6.20
+0.20 (3.33%)
Nov 20, 2024, 4:00 PM EST - Market closed
Pulmonx Market Cap
Pulmonx has a market cap or net worth of $244.82 million as of November 21, 2024. Its market cap has decreased by -33.22% in one year.
Market Cap
244.82M
Enterprise Value
192.85M
1-Year Change
-33.22%
Ranking
Category
Stock Price
$6.20
Market Cap Chart
Since the IPO on October 1, 2020, Pulmonx's market cap has decreased from $1.33B to $244.82M, a decrease of -81.64%. That is a compound annual growth rate of -33.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 244.82M | -49.87% |
| Dec 29, 2023 | 488.43M | 54.88% |
| Dec 30, 2022 | 315.36M | -73.31% |
| Dec 31, 2021 | 1.18B | -52.01% |
| Dec 31, 2020 | 2.46B | 84.60% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pyxis Oncology | 240.84M |
| Neurogene | 239.21M |
| Lifecore Biomedical | 237.53M |
| Inventiva | 236.08M |
| Electromed | 235.30M |
| Eledon Pharmaceuticals | 231.19M |
| Aurora Cannabis | 231.12M |
| Cybin | 231.11M |